PMC:7340249 / 7922-9074
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T24 | 230-235 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T25 | 456-461 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T26 | 986-990 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T11 | 230-235 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T12 | 456-461 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T13 | 986-990 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 161 | 29-37 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 174 | 59-67 | Species | denotes | patients | Tax:9606 |
| 175 | 117-125 | Species | denotes | patients | Tax:9606 |
| 176 | 329-336 | Species | denotes | patient | Tax:9606 |
| 177 | 501-508 | Species | denotes | patient | Tax:9606 |
| 178 | 88-108 | Disease | denotes | respiratory symptoms | MESH:D012818 |
| 179 | 191-199 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 180 | 217-225 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 181 | 368-376 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 182 | 386-398 | Disease | denotes | co-infection | MESH:D060085 |
| 183 | 432-440 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 184 | 487-495 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 185 | 561-569 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 187 | 714-739 | Disease | denotes | graft versus host disease | MESH:D006086 |
| 189 | 909-917 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T54 | 29-37 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T55 | 191-199 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T56 | 217-225 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T57 | 368-376 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T58 | 389-398 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T59 | 432-440 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T60 | 487-495 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T61 | 561-569 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T62 | 714-739 | Disease | denotes | graft versus host disease | http://purl.obolibrary.org/obo/MONDO_0013730 |
| T63 | 909-917 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T61 | 135-136 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T62 | 167-168 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T63 | 208-212 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T64 | 230-235 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T65 | 337-340 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T66 | 341-342 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T67 | 359-363 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T68 | 384-385 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T69 | 423-427 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T70 | 456-461 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T71 | 921-922 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T72 | 967-970 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T73 | 986-990 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T22 | 298-301 | Chemical | denotes | BAL | http://purl.obolibrary.org/obo/CHEBI_64198 |
| T23 | 793-797 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T24 | 825-830 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T25 | 836-858 | Chemical | denotes | calcineurin inhibitors | http://purl.obolibrary.org/obo/CHEBI_37153 |
| T26 | 836-847 | Chemical | denotes | calcineurin | http://purl.obolibrary.org/obo/CHEBI_53439 |
| T27 | 848-858 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 836-847 | http://purl.obolibrary.org/obo/GO_0004723 | denotes | calcineurin |
| T2 | 836-847 | http://purl.obolibrary.org/obo/GO_0004722 | denotes | calcineurin |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T47 | 0-54 | Sentence | denotes | • Diagnosis and treatment of COVID-19 in HSCT patients |
| T48 | 55-265 | Sentence | denotes | For patients with upper or lower respiratory symptoms and for patients who have a history of close contact with a person diagnosed with COVID-19, RT-PCR test for COVID-19 and chest CT scan should be considered. |
| T49 | 266-412 | Sentence | denotes | Routine bronchoalveolar lavage (BAL) is not recommended if the patient has a positive RT-PCR test for COVID-19 unless a co-infection is suspected. |
| T50 | 413-580 | Sentence | denotes | If RT-PCR test for COVID-19 is positive or chest CT scan is suspicious of COVID-19, the patient should be managed and treated according to national COVID-19 guideline. |
| T51 | 581-636 | Sentence | denotes | Optimal management strategies have not been determined. |
| T52 | 637-680 | Sentence | denotes | Supportive care is the mainstay of therapy. |
| T53 | 681-787 | Sentence | denotes | For prophylaxis and treatment of graft versus host disease, immunosuppressive therapy should be continued. |
| T54 | 788-882 | Sentence | denotes | Drug-drug interactions of anti-viral drugs with calcineurin inhibitors should be kept in mind. |
| T55 | 883-991 | Sentence | denotes | Finally, the emergence of COVID-19 is a global crisis that the transplant community has been forced to face. |
| T56 | 992-1152 | Sentence | denotes | We should learn from our experiences and implement the best possible strategies in order to protect our transplant recipients and also the healthcare providers. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T82 | 29-37 | SP_7 | denotes | COVID-19 |
| T83 | 88-99 | UBERON:0001004 | denotes | respiratory |
| T84 | 169-175 | NCBITaxon:1 | denotes | person |
| T85 | 191-199 | SP_7 | denotes | COVID-19 |
| T86 | 217-225 | SP_7 | denotes | COVID-19 |
| T87 | 230-235 | UBERON:0001443 | denotes | chest |
| T88 | 274-289 | UBERON:0002186 | denotes | bronchoalveolar |
| T89 | 368-376 | SP_7 | denotes | COVID-19 |
| T90 | 432-440 | SP_7 | denotes | COVID-19 |
| T91 | 456-461 | UBERON:0001443 | denotes | chest |
| T92 | 487-495 | SP_7 | denotes | COVID-19 |
| T93 | 561-569 | SP_7 | denotes | COVID-19 |
| T94 | 741-758 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
| T95 | 788-792 | CHEBI:23888;CHEBI:23888 | denotes | Drug |
| T96 | 793-797 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T97 | 814-819 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
| T98 | 819-824 | NCBITaxon:10239 | denotes | viral |
| T99 | 825-830 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T100 | 848-858 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T101 | 909-917 | SP_7 | denotes | COVID-19 |
| T102 | 1002-1007 | GO:0007612 | denotes | learn |
| T55450 | 29-37 | SP_7 | denotes | COVID-19 |
| T70785 | 88-99 | UBERON:0001004 | denotes | respiratory |
| T79988 | 169-175 | NCBITaxon:1 | denotes | person |
| T49879 | 191-199 | SP_7 | denotes | COVID-19 |
| T96999 | 217-225 | SP_7 | denotes | COVID-19 |
| T17155 | 230-235 | UBERON:0001443 | denotes | chest |
| T59111 | 274-289 | UBERON:0002186 | denotes | bronchoalveolar |
| T10704 | 368-376 | SP_7 | denotes | COVID-19 |
| T74883 | 432-440 | SP_7 | denotes | COVID-19 |
| T73801 | 456-461 | UBERON:0001443 | denotes | chest |
| T18898 | 487-495 | SP_7 | denotes | COVID-19 |
| T75053 | 561-569 | SP_7 | denotes | COVID-19 |
| T73467 | 741-758 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
| T14713 | 788-792 | CHEBI:23888;CHEBI:23888 | denotes | Drug |
| T72900 | 793-797 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T48694 | 814-819 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
| T93585 | 819-824 | NCBITaxon:10239 | denotes | viral |
| T6723 | 825-830 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T51690 | 848-858 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T28044 | 909-917 | SP_7 | denotes | COVID-19 |
| T78810 | 1002-1007 | GO:0007612 | denotes | learn |